19 nuovi farmaci in commercio

Nuove specialità medicinali: Enantyum, Gottart, Nalnar, Seacor. 13 Nuovi farmaci equivalenti

Nuove specialità medicinali
ENANTYUM 10 buste 25 mg 10 ml dexketoprofene sale di trometamolo
A.MENARINI AIC:033656416 -€ C/OTC in commercio dal:26/06/2019

GOTTART 28 cpr riv 80 mg febuxostat emidrato
S.F. GROUP AIC:045559010 16,97€ A/RR in commercio dal:28/06/2019

GOTTART 28 cpr riv 120 mg febuxostat emidrato
S.F. GROUP AIC:045559022 16,97€ A/RR in commercio dal:28/06/2019

NALNAR 7 cpr sublinguali 2 mg + 0,5 mg buprenorfina/naloxone
BRUNO FARMACEUTICI AIC:045712015 4,56€ A/RMR in commercio dal:01/07/2019

NALNAR 7 cpr sublinguali 8 mg + 2 mg buprenorfina/naloxone
BRUNO FARMACEUTICI AIC:045712039 16,52€ A/RMR in commercio dal:01/07/2019

SEACOR 30 cps molli 1000 mg omega polienoici (esteri etilici di acidi grassi polinsaturi)
SPA AIC:027616034 16,90€ Cnn / RR in commercio dal:01/07/2019

Nuovi farmaci equivalenti
DASATINIB EG 60 cpr riv 50 mg dasatinib monoidrato
EG AIC:045575038 3.985,10€ H/RNRL in commercio dal:01/07/2019

DASATINIB EG 30 cpr riv 80 mg dasatinib monoidrato
EG AIC:045575166 3.985,10€ H/RNRL in commercio dal:01/07/2019

DASATINIB EG 30 cpr riv 100 mg dasatinib monoidrato
EG AIC:045575180 3.985,10€ H/RNRL in commercio dal:01/07/2019

DASATINIB EG 30 cpr riv 140 mg dasatinib monoidrato
EG AIC:045575204 3.985,10€ H/RNRL in commercio dal:01/07/2019

EZETIMIBE SIMVASTATINA ALMUS 30 cpr 10 mg + 10 mg ezetimibe/simvastatina
ALMUS AIC:045909013 17,10€ A/RR in commercio dal:01/07/2019

EZETIMIBE SIMVASTATINA ALMUS 30 cpr 10 mg + 20 mg ezetimibe/simvastatina
ALMUS AIC:045909025 17,82€ A/RR in commercio dal:01/07/2019

EZETIMIBE SIMVASTATINA ALMUS 30 cpr 10 mg + 40 mg ezetimibe/simvastatina
ALMUS AIC:045909037 18,40€ A/RR in commercio dal:01/07/2019

RAMIPRIL EUROGENERICI 28 cpr 5 mg ramipril
EG AIC:037439155 3,30€ A/RR in commercio dal:25/06/2019

SOLIFENACINA AUROBINDO 30 cpr riv 5 mg solifenacina succinato
AUROBINDO AIC:044099012 52,00€ C/RR in commercio dal:26/06/2019

VARDENAFIL EG 4 cpr riv 5 mg vardenafil cloridrato triidrato
EG AIC:045154010 15,20€ C/RR in commercio dal:25/06/2019

VARDENAFIL EG 2 cpr riv 10 mg vardenafil cloridrato triidrato
EG AIC:045154046 15,20€ C/RR in commercio dal:25/06/2019

VARDENAFIL EG 4 cpr riv 10 mg vardenafil cloridrato triidrato
EG AIC:045154059 30,40€ C/RR in commercio dal:25/06/2019

VARDENAFIL EG 4 cpr riv 20 mg vardenafil cloridrato triidrato
EG AIC:045154109 57,60€ C/RR in commercio dal:25/06/2019

CHMP: parere negativo per romosozumab, Amgen e Ucb faranno ricorso
Farmaci: 4 cessate commercializzazioni

Flash news simili

Editoriali

L’esperto risponde